GSK
(NYSE:GSK)
$39.60
-0.35[-0.88%]
At close: Apr 17
$39.60
0[0.00%]
After Hours: 4:03PM EDT
Q1 2024 Earnings in 14 days from now on Wed May 1st, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

GSK Stock (NYSE:GSK), Quotes and News Summary

GSK Stock (NYSE: GSK) stock price, news, charts, stock research, profile.

Open$39.720
Close$39.600
Volume / Avg.3.208M / 3.594M
Day Range39.440 - 39.850
52 Wk Range33.330 - 43.840
Market Cap$80.904B
P/E Ratio13.369
Dividend Yield3.670%
ExchangeNYSE
RSI
27
Short Interest
0.24%
Days to Cover2.28

Recent News

GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years
Lasting protection against shingles for adults over 50 with GSK's RZV vaccine. New data from ZOSTER-049 trial reveals over a decade of high efficacy. Plus, GSK's oral antibiotic, gepotidacin, shows promising results for uncomplicated gonorrhea treatment.
Vandana Singh
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Avi Kapoor
CureVac, GSK Partner Release Data On Influenza Vaccine Study
CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen coverage with acceptable safety. Positive findings against influenza A strains prompt further optimization for influenza B strains.
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
1
Jan
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.2
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About GSK Plc
Sector
Health Care
Industry
Pharmaceuticals
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wi...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GSK
NVO

FAQ

Q

How do I buy GSK (GSK) stock?

A

You can purchase shares of GSK (NYSE: GSK) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are GSK's (GSK) competitors?

A

Other companies in GSK’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for GSK (GSK) stock?

A

The latest price target for GSK (NYSE: GSK) was reported by Guggenheim on Monday, March 4, 2024. The analyst firm set a price target for 0.00 expecting GSK to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for GSK (GSK)?

A

The stock price for GSK (NYSE: GSK) is $39.6 last updated April 17, 2024 at 4:03 PM EDT.

Q

Does GSK (GSK) pay a dividend?

A

A quarterly cash dividend of $0.41 per share of Class A Common Stock. The quarterly cash dividend was payable on April 11, 2024 to stockholders of record on February 22, 2024.

Q

When is GSK (NYSE:GSK) reporting earnings?

A

GSK’s Q1 earnings are confirmed for Wednesday, May 1, 2024.

Q

Is GSK (GSK) going to split?

A

There is no upcoming split for GSK.

Q

What sector and industry does GSK (GSK) operate in?

A

GSK is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

People Also Watch